{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:56:20Z","timestamp":1787806580688,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.biopha.2021.111392","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T04:56:25Z","timestamp":1613883385000},"page":"111392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Ethyl pyruvate supplemented in drinking water ameliorates experimental nonalcoholic steatohepatitis"],"prefix":"10.1016","volume":"137","author":[{"given":"Xiujing","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengtao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runar J.","family":"Strand-Amundsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor Inge","family":"Tonnessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runkuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.111392_bib1","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"Loomba","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2021.111392_bib2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2468-1253(16)30011-5","article-title":"Pathogenesis and novel treatment options for non-alcoholic steatohepatitis","volume":"1","author":"Wong","year":"2016","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2021.111392_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/liv.13302","article-title":"Therapies in non-alcoholic steatohepatitis (NASH)","volume":"37","author":"Oseini","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.biopha.2021.111392_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000282080","article-title":"Epidemiology of non-alcoholic fatty liver disease","volume":"28","author":"Bellentani","year":"2010","journal-title":"Dig. Dis."},{"key":"10.1016\/j.biopha.2021.111392_bib5","first-page":"25","article-title":"Pathogenesis of steatohepatitis: insights from the study of animal models","volume":"70","author":"Leclercq","year":"2007","journal-title":"Acta Gastroenterol. Belg."},{"key":"10.1016\/j.biopha.2021.111392_bib6","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","article-title":"Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States","volume":"141","author":"Charlton","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2021.111392_bib7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","article-title":"A position statement on NAFLD\/NASH based on the EASL 2009 special conference","volume":"53","author":"Ratziu","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2021.111392_bib8","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1185\/03007995.2010.506375","article-title":"Population-based risk factors and resource utilization for HCC: US perspective","volume":"26","author":"Sanyal","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.biopha.2021.111392_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jceh.2015.06.004","article-title":"Animal models correlating immune cells for the development of NAFLD\/NASH","volume":"5","author":"Lyer","year":"2015","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.biopha.2021.111392_bib10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clinbiochem.2004.10.014","article-title":"Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management","volume":"38","author":"Portincasa","year":"2005","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.biopha.2021.111392_bib11","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0168-8278(03)00097-7","article-title":"Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics","volume":"38","author":"Solga","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2021.111392_bib12","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1053\/gast.2000.19267","article-title":"Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis","volume":"119","author":"Cope","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2021.111392_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/s12950-016-0144-1","article-title":"Ethyl pyruvate is a novel anti-inflammatory agent to treat multiple inflammatory organ injuries","volume":"13","author":"Yang","year":"2016","journal-title":"J. Inflamm."},{"key":"10.1016\/j.biopha.2021.111392_bib14","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1097\/01.CCM.0000178177.03979.CE","article-title":"Ethyl pyruvate improves systemic and hepatosplanchnic hemodynamics and prevents lipid peroxidation in a porcine model of resuscitated hyperdynamic endotoxemia","volume":"33","author":"Hauser","year":"2005","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.biopha.2021.111392_bib15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/jat.1236","article-title":"Protective effect of ethyl pyruvate on msp rat leukocytes damaged by alcohol intake","volume":"27","author":"Fedeli","year":"2007","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.biopha.2021.111392_bib16","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0022-2143(03)00138-0","article-title":"Ethyl pyruvate ameliorates acute alcoholic-induced liver injury and inflammation in mice","volume":"142","author":"Yang","year":"2003","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.biopha.2021.111392_bib17","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/01.CCM.0000130835.65462.06","article-title":"Ringer\u2019s ethyl pyruvate solution ameliorates distant organ injury in a murine model of acute necrotizing pancreatitis","volume":"32","author":"Yang","year":"2004","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.biopha.2021.111392_bib18","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/jn\/130.9.2131","article-title":"Starvation impairs antioxidant defense in fatty livers of rats fed a choline-deficient diet","volume":"130","author":"Grattagliano","year":"2000","journal-title":"J. Nutr."},{"key":"10.1016\/j.biopha.2021.111392_bib19","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/hep.21614","article-title":"CCAAT\/ enhancing binding protein \u03b2 deletion in mice attenuates inflammation, endoplasmic reticulum stress and lipid accumulation in diet-induced nonalcoholic steatohepatitis","volume":"45","author":"Rahman","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2021.111392_bib20","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jbt.20177","article-title":"Genes of antioxidant response undergo upregulation in a rodent model of nonalcoholic steatohepatitis","volume":"21","author":"Lickteig","year":"2007","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.biopha.2021.111392_bib21","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Nonalcoholic steatohepatitis clinical research network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2021.111392_bib22","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jss.2008.04.004","article-title":"Ethyl pyruvate ameliorates liver injury secondary to severe acute pancreatitis","volume":"153","author":"Yang","year":"2009","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.biopha.2021.111392_bib23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-\u03baB in the liver-linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2021.111392_bib24","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1053\/gast.2002.35391","article-title":"HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice","volume":"123","author":"Sappington","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2021.111392_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/liv.13301","article-title":"Pathology of non-alcoholic fatty liver disease","volume":"37","author":"Bedossa","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.biopha.2021.111392_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/hep.20533","article-title":"Lipopolysaccharide-binding protein modulates acetaminophen-induced liver injury in mice","volume":"41","author":"Su","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2021.111392_bib27","doi-asserted-by":"crossref","first-page":"22672","DOI":"10.1074\/jbc.M114.552141","article-title":"High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD)","volume":"289","author":"Ge","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2021.111392_bib28","doi-asserted-by":"crossref","first-page":"G838","DOI":"10.1152\/ajpgi.00151.2013","article-title":"HMGB1 recruits hepatic stellate cells and liver endothelial cells to the sites of ethanol-induced parenchymal cell injury","volume":"305","author":"Seo","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biopha.2021.111392_bib29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jss.2018.02.049","article-title":"Bile and circulating HMGB1 contributes to systemic inflammation in obstructive jaundice","volume":"228","author":"Yang","year":"2018","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.biopha.2021.111392_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00538","article-title":"Critical roles of Kupffer Cells in the pathogenesis of alcoholic liver disease: from basic science to clinical trials","volume":"7","author":"Zeng","year":"2016","journal-title":"Front. Immunol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221001773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221001773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:33:59Z","timestamp":1760099639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221001773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":30,"alternative-id":["S0753332221001773"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111392","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ethyl pyruvate supplemented in drinking water ameliorates experimental nonalcoholic steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111392"}}